Skip to content

ANEBULO PHARMACEUTICALS, INC.: filings

Every ANEBULO PHARMACEUTICALS, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 20 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-02-12fiscal Q2 202629900001493152-26-006446
10-Q2025-11-13fiscal Q1 202627560001493152-25-022350
10-K2025-09-29fiscal FY 202529580001493152-25-016015
10-Q2025-05-13fiscal Q3 202529930001641172-25-009975
10-Q2025-02-14fiscal Q2 202528870001493152-25-006893
10-Q2024-11-13fiscal Q1 202526530001493152-24-045151
10-K2024-09-25fiscal FY 202428540001493152-24-038127
10-Q2024-05-15fiscal Q3 202428880001493152-24-019922
10-Q2024-02-13fiscal Q2 202428840001493152-24-006103
10-Q2023-11-14fiscal Q1 202425500001493152-23-041171
10-K2023-09-22fiscal FY 202324470001493152-23-033452
10-Q2023-05-11fiscal Q3 202322700001493152-23-016382
10-Q2023-02-10fiscal Q2 202322660001493152-23-004203
10-Q2022-11-10fiscal Q1 202321420001493152-22-031239
10-K2022-09-09fiscal FY 202225480001493152-22-025448
10-Q2022-05-11fiscal Q3 202222670001493152-22-012848
10-Q2022-02-11fiscal Q2 202218530001493152-22-003883
10-Q2021-11-12fiscal Q1 202119390001493152-21-028031
10-K2021-09-22fiscal FY 202124400001493152-21-023373
10-Q2021-06-21fiscal Q3 202025420001493152-21-014879

Inspect the source

Entity
ANEBULO PHARMACEUTICALS, INC. / CIK 0001815974
Captured
2026-09-21T17:28:29.433Z
SEC response SHA-256
9b7fbc7aa6627d1ba25b78b2b6216133888564e8abee26c007f1576dedf9e9dd

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001815974.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))